3505 results for «25»
3505 results
Technical challenges and optimal device choice for complex TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
TAVI is a mature procedure: implications for lifelong management of young and old patients
27 Nov 2022 – From PCR London Valves 2022
Take a look at these presentations to learn more about TAVI implications for lifelong management, to understand what is happening in the field of aortic valve intervention and to appreciate the evidence governing the application of this procedure in the lifetime journey of patients with aortic...
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
Primary mitral regurgitation: treatment options when the anatomy is simple
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.
Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning
27 Nov 2022 – From PCR London Valves 2022
In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.
Tricuspid interventions
27 Nov 2022 – From PCR London Valves 2022
How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!
A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring
28 Nov 2022 – From PCR London Valves 2022
Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.
Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management
28 Nov 2022 – From PCR London Valves 2022
Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.
The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems
27 Nov 2022 – From PCR London Valves 2022
In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.
Therapy of valvular heart diseases: a patient-centred innovation journey
27 Nov 2022 – From PCR London Valves 2022
Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...
Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease
28 Nov 2022 – From PCR London Valves 2022
Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.
Contemporary best clinical practice for TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.
Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
TAVI: new devices and procedural refinements
27 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
Rapid-fire clinical cases: session 2
27 Nov 2022 – From PCR London Valves 2022
Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!
